Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer.
Qian WuHongyun ZhengJian GuYanfang ChengBin QiaoJingwei WangLiang XiongSi SunZegang WuAnyu BaoYongqing TongPublished in: Journal of clinical laboratory analysis (2021)
CTC is significantly increased in the patients with breast cancer, and the detective level is associated with disease progress.